If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Epirubicin Medicine & Life Sciences
Survival Medicine & Life Sciences
Adjuvant Chemotherapy Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1972 2019

  • 19974 Citations
  • 66 h-Index
  • 344 Article
  • 3 Review article
  • 1 Chapter
  • 1 Letter

“Normal values” for the lymphocyte cytokinesis-block micronucleus cytome parameters: Repeatability and reproducibility in a healthy reference population

Bolognesi, C., Bonelli, L., Compalati, A., Ferla, V., Stagnaro, L., Ubezio, G. & Bruzzi, P., Feb 20 2019, In : Science of the Total Environment. 652, p. 513-522 10 p.

Research output: Contribution to journalArticle

Lymphocytes
Assays
Blood
blood
assay

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Maugeri Centre for Telehealth and Telecare (MCTT), 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

1 Citations

Different view on larynx preservation evidence-based treatment recommendations

Licitra, L., Bonomo, P., Sanguineti, G., Bacigalupo, A., Baldi, G. G., Valerini, S. & Bruzzi, P., May 1 2018, In : Journal of Clinical Oncology. 36, 13, p. 1376-1377 2 p.

Research output: Contribution to journalLetter

Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study

Pavanello, S., Varesco, L., Gismondi, V., Bruzzi, P. & Bolognesi, C., May 1 2018, In : PLoS One. 13, 5, e0197522.

Research output: Contribution to journalArticle

telomeres
Telomere
case-control studies
breast neoplasms
Case-Control Studies
62 Citations

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years

Pan, H., Gray, R., Braybrooke, J., Davies, C., Taylor, C., McGale, P., Peto, R., Pritchard, K. I., Bergh, J., Dowsett, M., Hayes, D. F., EBCTCG, Bighin, C., Bruzzi, P., Del Mastro, L., Dozin, B., Pronzato, P. & Sertoli, M. R., Nov 9 2017, In : New England Journal of Medicine. 377, 19, p. 1836-1846 11 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Recurrence
Therapeutics
Estrogen Receptors
Neoplasms